HIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progression

Keith, Brian, Johnson, Randall S., Simon, M. Celeste·2012·Nature Reviews Cancer

Cited by (1,008)

Items 201–300 of 1,008

  1. IRP1 regulates erythropoiesis and systemic iron homeostasis by controlling HIF2α mRNA translation
    Nicole Wilkinson, Kostas Pantopoulos · 2013 · Blood
  2. Oxygenation of adipose tissue: A human perspective
    Ioannis G. Lempesis, Rens L. J. van Meijel, Konstantinos N. Manolopoulos, Gijs H. Goossens · 2019 · Acta Physiologica
  3. Targeting hypoxia-inducible factor-1, for cancer treatment: Recent advances in developing small-molecule inhibitors from natural compounds
    Zhaowu Ma, Xiaoqiang Xiang, Shiya Li, Peng Xie, Quan Gong, Boon-Cher Goh, Lingzhi Wang · 2020 · Seminars in Cancer Biology
  4. Role of Wnt/β‐Catenin Signaling in the Chemoresistance Modulation of Colorectal Cancer
    Yuan, Shengli, Tao, Fengying, Zhang, Xinglin, Zhang, Yan, Sun, Xingxing, Wu, Dapeng · 2020 · BioMed Research International
  5. The tumor suppressor folliculin regulates AMPK-dependent metabolic transformation
    Ming Yan, Marie‐Claude Gingras, Elaine A. Dunlop, Yann Nouët, Fanny Dupuy, Zahra Jalali, Elite Possik, Barry J. Coull, Dmitri Kharitidi, Anders Bondo Dydensborg et al. · 2014 · Journal of Clinical Investigation
  6. Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis
    Remya Raja, Smita Kale, D Thorat, Gowrishankar Soundararajan, Kirti Lohite, Anupama Dutt Mane, Swapnil V. Karnik, Gopal C. Kundu · 2013 · Oncogene
  7. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway
    Chien-Wei Tseng, Wen‐Hung Kuo, Shih‐Hsuan Chan, Hong‐Lin Chan, King‐Jen Chang, Lu‐Hai Wang · 2018 · Cancer Research
  8. Cell intrinsic and extrinsic activators of the unfolded protein response in cancer: Mechanisms and targets for therapy
    Feven Tameire, Ioannis I. Verginadis, Constantinos Koumenis · 2015 · Seminars in Cancer Biology
  9. The Key Role of Nitric Oxide in Hypoxia: Hypoxic Vasodilation and Energy Supply–Demand Matching
    Michele Umbrello, Alex Dyson, Martin Feelisch, Mervyn Singer · 2013 · Antioxidants and Redox Signaling
  10. Metabolic Reprogramming in Brain Tumors
    Sriram Venneti, Craig B. Thompson · 2017 · Annual Review of Pathology Mechanisms of Disease
  11. Arginase 2 Suppresses Renal Carcinoma Progression via Biosynthetic Cofactor Pyridoxal Phosphate Depletion and Increased Polyamine Toxicity
    Joshua D. Ochocki, Sanika Khare, Markus Hess, Daniel Ackerman, Bo Qiu, Jennie I. Daisak, Andrew J. Worth, Nan Lin, Pearl Lee, Hong Jian Xie et al. · 2018 · Cell Metabolism
  12. Mechanisms and Consequences of Oxygen and Carbon Dioxide Sensing in Mammals
    Eoin P. Cummins, Moritz J. Strowitzki, Cormac T. Taylor · 2019 · Physiological Reviews
  13. Mechanisms of Regulated Cell Death: Current Perspectives
    Sara Francesca Santagostino, Charles‐Antoine Assenmacher, James C. Tarrant, Adeyemi O. Adedeji, Enrico Radaelli · 2021 · Veterinary Pathology
  14. An ID2-dependent mechanism for VHL inactivation in cancer
    Sang Bae Lee, Veroniquè Frattini, Mukesh Bansal, Angelica M. Castano, Dan Sherman, Keino Hutchinson, Jeffrey N. Bruce, Andrea Califano, Guangchao Liu, Timothy J. Cardozo et al. · 2016 · Nature
  15. Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer
    Jiayi Zhang, Mingxuan Yao, Shiting Xia, Fancai Zeng, Qiuyu Liu · 2025 · Cellular & Molecular Biology Letters
  16. The role of hypoxia-inducible factor-2 in digestive system cancers
    Zhao, J, Du, F, Shen, G, Zheng, F, Xu, B · 2015 · Cell Death & Disease
  17. Bone marrow adipocytes promote the Warburg phenotype in metastatic prostate tumorsviaHIF-1α activation
    Jonathan D. Diedrich, Erandi N. Rajagurubandara, Mackenzie K. Herroon, Gargi Mahapatra, Maik Hüttemann, Izabela Podgorski · 2016 · Oncotarget
  18. Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects
    Hongxia Jiang, Hanqiu Zhao, Mengzhe Zhang, Yuanzhou He, Xiaochen Li, Yongjian Xu, Xiansheng Liu · 2022 · Frontiers in Immunology
  19. HIF-2α is indispensable for regulatory T cell function
    Hsu, Tzu-Sheng, Lin, Yen-Lin, Wang, Yu-An, Mo, Shu-Ting, Chi, Po-Yu, Lai, Alan Chuan-Ying, Pan, Hsuan-Yin, Chang, Ya-Jen, Lai, Ming-Zong · 2020 · Nature Communications
  20. Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells
    Haitao Zhu, Dongqing Wang, Yanfang Liu, Zhaoliang Su, Lirong Zhang, Fangfang Chen, Yuepeng Zhou, Yingying Wu, Ming Yu, Zhijian Zhang et al. · 2013 · Cancer Cell International
  21. Precise Subcellular Organelle Targeting for Boosting Endogenous‐Stimuli‐Mediated Tumor Therapy
    Wenyao Zhen, Shangjie An, Shuqi Wang, Wenxue Hu, Yujie Li, Xiue Jiang, Jinghong Li · 2021 · Advanced Materials
  22. The mTOR and PP2A pathways regulate PHD2 phosphorylation to fine-tune HIF1α levels and colorectal cancer cell survival under hypoxia
    Di Conza, Giusy, Trusso Cafarello, Sarah, Loroch, Stefan, Mennerich, Daniela, Deschoemaeker, Sofie, Di Matteo, Mario, Ehling, Manuel, Gevaert, Kris, Prenen, Hans, Zahedi, Rene Peiman et al. · 2017 · Cell Reports
  23. Pharmacological targeting of the HIF hydroxylases – A new field in medicine development
    Mun Chiang Chan, James P. Holt‐Martyn, Christopher John Schofield, Peter John Ratcliffe · 2016 · Molecular Aspects of Medicine
  24. Intratumoral oxygen gradients mediate sarcoma cell invasion
    Daniel M. Lewis, Kyung Min Park, Vitor Tang, Yu Xu, Koreana Pak, T.S. Karin Eisinger‐Mathason, Marie Celeste Simon, Sharon Gerecht · 2016 · Proceedings of the National Academy of Sciences
  25. A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells
    Philippe Icard, Hubert Lincet · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  26. Hypoxia-inducible factors in cancer stem cells and inflammation
    Gong Peng, Yang Liu · 2015 · Trends in Pharmacological Sciences
  27. Multidrug resistance in glioblastoma stem-like cells: Role of the hypoxic microenvironment and adenosine signaling
    Daniel Uribe, Ángelo Torres, José Dellis Rocha, Ignacio Niechi, Carlos E. Oyarzun, Luis Sobrevía, Rody San Martín, Claudia Quezada · 2017 · Molecular Aspects of Medicine
  28. Metabolic rivalry: circadian homeostasis and tumorigenesis
    Kenichiro Kinouchi, Paolo Sassone‐Corsi · 2020 · Nature reviews. Cancer
  29. Role of AHR and HIF-1α in Glioblastoma Metabolism
    Galina Gabriely, Michael A. Wheeler, Maisa C. Takenaka, Francisco Javier Quintana · 2017 · Trends in Endocrinology and Metabolism
  30. Pheochromocytoma
    Frederick‐Anthony Farrugia, Anestis A. Charalampopoulos · 2019 · Endocrine Regulations
  31. Obstructive Sleep Apnea Syndrome and Metabolic Diseases
    Min Li, Xiaoying Li, Yan Lü · 2018 · Endocrinology
  32. Models of intermittent hypoxia and obstructive sleep apnea: molecular pathways and their contribution to cancer
    Imre Hunyor, Kristina M. Cook · 2018 · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
  33. Structural characterization of mammalian bHLH-PAS transcription factors
    Wu, Dalei, Rastinejad, Fraydoon · 2017 · Current Opinion in Structural Biology
  34. Iron Deprivation in Cancer––Potential Therapeutic Implications
    Jessica L. Heath, Joshua M. Weiss, Catherine Lavau, Daniel S. Wechsler · 2013 · Nutrients
  35. Oxygen-sensing mechanisms across eukaryotic kingdoms and their roles in complex multicellularity
    Emma U. Hammarlund, Emily Flashman, Sofie Mohlin, Francesco Licausi · 2020 · Science
  36. The irradiated tumor microenvironment: role of tumor-associated macrophages in vascular recovery
    Jeffery Scott Russell, J. Martin Brown · 2013 · Frontiers in Physiology
  37. Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma
    Romain Riscal, Caroline J. Bull, Clementina Mesaros, Jennifer M. Finan, Madeleine Carens, Elaine S. Ho, Jimmy P. Xu, Jason Godfrey, Paul Brennan, Mattias Johansson et al. · 2021 · Cancer Discovery
  38. ITPR1 Protects Renal Cancer Cells against Natural Killer Cells by Inducing Autophagy
    Messai, Yosra, Noman, Muhammad Zaeem, Hasmim, Meriem, Janji, Bassam, Tittarelli, Andrés, Boutet, Marie, Baud, Véronique, Viry, Elodie, Billot, Katy, Nanbakhsh, Arash et al. · 2014 · Cancer Research
  39. Prolyl 4‐hydroxylases, master regulators of the hypoxia response
    Johanna Myllyharju · 2013 · Acta Physiologica
  40. Cyclic Hypoxia: An Update on Its Characteristics, Methods to Measure It and Biological Implications in Cancer
    Samuel B. Bader, Mark W. Dewhirst, Ester M. Hammond · 2020 · Cancers
  41. Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
    Takanori Eguchi, Chiharu Aoki Sogawa, Yuka Okusha, Kenta Uchibe, Ryosuke Iinuma, Kisho Ono, Keisuke Nakano, Jun Murakami, Manabu Itoh, Kazuya Arai et al. · 2018 · PLoS ONE
  42. HIF-1α in Myeloid Cells Promotes Adipose Tissue Remodeling Toward Insulin Resistance
    Akiko Takikawa, Arshad Mahmood, Allah Nawaz, Tomonobu Kado, Keisuke Okabe, Seiji Yamamoto, Aminuddin Aminuddin, Satoko Senda, Koichi Tsuneyama, Masashi Ikutani et al. · 2016 · Diabetes
  43. Design and Activity of Specific Hypoxia-Inducible Factor-2α (HIF-2α) Inhibitors for the Treatment of Clear Cell Renal Cell Carcinoma: Discovery of Clinical Candidate (S)-3-((2,2-Difluoro-1-hydroxy-7-(methylsulfonyl)-2,3-dihydro-1H-inden-4-yl)oxy)-5-fluorobenzonitrile (PT2385)
    Paul M. Wehn, James P. Rizzi, Darryl D. Dixon, Jonas A. Grina, Stephen T. Schlachter, Bin Wang, Rui Xu, Hanbiao Yang, Xinlin Du, Guangzhou Han et al. · 2018 · Journal of Medicinal Chemistry
  44. Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
    Ying Wen, Xueqiong Zhou, Meiting Lu, Meiling He, Ye Tian, Lixia Liu, Mengnan Wang, Wenchong Tan, Yaotang Deng, Xushan Yang et al. · 2018 · Oncogene
  45. The role of hypoxia‐inducible factor‐2 alpha in angiogenesis
    Christina D. Befani, Panagiotis Liakos · 2018 · Journal of Cellular Physiology
  46. Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia‐inducible factors HIF 1α and HIF 2α
    Jennifer Schöning, Michael J. Monteiro, Wenyi Gu · 2016 · Clinical and Experimental Pharmacology and Physiology
  47. Role of p53 in the Regulation of the Inflammatory Tumor Microenvironment and Tumor Suppression
    Ikuno Uehara, Nobuyuki Tanaka · 2018 · Cancers
  48. Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers
    John C. Chappell, Laura Beth Payne, W. Kimryn Rathmell · 2019 · Journal of Clinical Investigation
  49. Micromanaging aerobic respiration and glycolysis in cancer cells
    Ayla Orang, Janni Petersen, Ross Allan McKinnon, Michael Michael · 2019 · Molecular Metabolism
  50. Knockdown of ANT2 reduces adipocyte hypoxia and improves insulin resistance in obesity
    Jong Bae Seo, Matthew Riopel, Pedro Cabrales, Jin Young Huh, Gautam Kumar Bandyopadhyay, Alexander Y. Andreyev, Anne N. Murphy, Scott C. Beeman, Gordon Ian Smith, Samuel Klein et al. · 2018 · Nature Metabolism
  51. HIF-1α Mediates Functional Switching of TGF-Β Signaling by Regulating the PKM mRNA Splicing and Metabolic Reprogramming in Non-Small Cell Lung Cancer
    Yiwei Huang, Zhencong Chen, Tao Lu, Guoshu Bi, Ming Li, Jiaqi Liang, Zhengyang Hu, Yuansheng Zheng, Jiacheng Yin, Junjie Xi et al. · 2020 · Journal of Experimental & Clinical Cancer Research
  52. Current Understanding of Hypoxia in Glioblastoma Multiforme and Its Response to Immunotherapy
    Jang Hyun Park, Heung Kyu Lee · 2022 · Cancers
  53. Updates on the genetics and the clinical impacts on phaeochromocytoma and paraganglioma in the new era
    Suja Pillai, Vinod Gopalan, Robert Anthony Smith, Alfred King-yin Lam · 2016 · Critical Reviews in Oncology/Hematology
  54. Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia‐reperfusion injury in heart
    Rianne Nederlof, Otto Eerbeek, Markus Werner Hollmann, Richard Southworth, Coert Jozef Zuurbier · 2013 · British Journal of Pharmacology
  55. Bidirectional modulation of HIF-2 activity through chemical ligands
    Dalei Wu, Xiaoyu Su, Jing-Ping Lu, Sheng Li, Becky L. Hood, Stefan Vasile, Nalini Potluri, Xiaotong Diao, Youngchang Kim, Sepideh Khorasanizadeh et al. · 2019 · Nature Chemical Biology
  56. Therapeutic Delivery of siRNA Silencing HIF-1 Alpha with Micellar Nanoparticles Inhibits Hypoxic Tumor Growth
    Xi‐Qiu Liu, Menghua Xiong, Xiaoting Shu, Rui-Zhi Tang, Jun Wang · 2012 · Molecular Pharmaceutics
  57. Hypoxia and fatty liver
    Tomohiro Suzuki · 2014 · World Journal of Gastroenterology
  58. Metabolism and epigenetics: a link cancer cells exploit
    Alessandro Carrer, Kathryn E. Wellen · 2014 · Current Opinion in Biotechnology
  59. Cutting Edge: Hypoxia-Induced Nanog Favors the Intratumoral Infiltration of Regulatory T Cells and Macrophages via Direct Regulation of TGF-β1
    Meriem Hasmim, Muhammad Zaeem Noman, Yosra Messai, Didier Bordereaux, Gwendoline Gros, Véronique Baud, Salem Chouaı̈b · 2013 · The Journal of Immunology
  60. Myeloid-Derived Suppressor Cells in Colorectal Cancer
    Izabela Siemińska, Jarek Baran · 2020 · Frontiers in Immunology
  61. HIF-α Prolyl Hydroxylase Inhibitors and Their Implications for Biomedicine: A Comprehensive Review
    Kiichi Hirota · 2021 · Biomedicines
  62. Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α
    Wei Wan, Kesong Peng, M Li, Liping Qin, Zhangwei Tong, Jun Yan, Bing Shen, Chundong Yu · 2017 · Oncogene
  63. Hypoxia-inducible factor-1α induces multidrug resistance protein in colon cancer
    Yingqian Lv, Shan Zhao, Jinzhu Han, Likang Zheng, Zixin Yang, Li Zhao · 2015 · OncoTargets and Therapy
  64. An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs)
    Kiichi Hirota · 2018 · Free Radical Biology and Medicine
  65. Lipid metabolism reprogramming in renal cell carcinoma
    Gioia Heravi, Omid Yazdanpanah, Izabela Podgorski, Larry H. Matherly, Wanqing Liu · 2021 · Cancer and Metastasis Reviews
  66. Noncoding RNA in Oncogenesis: A New Era of Identifying Key Players
    Guorui Deng, Guangchao Sui · 2013 · International Journal of Molecular Sciences
  67. An epigenetic gateway to brain tumor cell identity
    Stephen C. Mack, Christopher G. Hubert, Tyler E. Miller, Michael D. Taylor, Jeremy N. Rich · 2015 · Nature Neuroscience
  68. The role of HIF1α in renal cell carcinoma tumorigenesis
    Lorraine J. Gudas, Leiping Fu, Denise R. Minton, Nigel Patrick Mongan, David M. Nanus · 2014 · Journal of Molecular Medicine
  69. Reactive oxygen species produced by altered tumor metabolism impacts cancer stem cell maintenance
    Kaysaw Tuy, Lucas Rickenbacker, Anita B. Hjelmeland · 2021 · Redox Biology
  70. A novel effect of DMOG on cell metabolism: direct inhibition of mitochondrial function precedes HIF target gene expression
    Alexander V. Zhdanov, Irina A. Okkelman, Fergus W. J. Collins, Silvia Melgar, Dmitri B. Papkovsky · 2015 · Biochimica et Biophysica Acta (BBA) - Bioenergetics
  71. Tumor-associated macrophages: a short compendium
    Hans Prenen, Massimiliano Mazzone · 2019 · Cellular and Molecular Life Sciences
  72. Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
    Diego Camuzi, Ísis Salviano Soares de Amorim, Luís Felipe Ribeiro Pinto, Leonardo Oliveira Trivilin, André Luiz Mencalha, Sheila Coelho Soares‐Lima · 2019 · Cells
  73. TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition
    Aurélie Morin, Judith Goncalves, Sophie Moog, Luis Jaime Castro‐Vega, Sylvie Job, Alexandre Buffet, Marie‐Joséphine Fontenille, Justine Woszczyk, Anne‐Paule Gimenez‐Roqueplo, Éric Letouzé et al. · 2020 · Cell Reports
  74. Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy
    Zhaowu Ma, Louis Zizhao Wang, Jun-Ting Cheng, Sze Tung Lam, Xiang Ma, Xiaoqiang Xiang, Andrea Li‐Ann Wong, Boon Cher Goh, Quan Gong, Gautam Sethi et al. · 2020 · Antioxidants and Redox Signaling
  75. Integrated single-cell transcriptomic analyses reveal that GPNMB-high macrophages promote PN-MES transition and impede T cell activation in GBM
    Aizhen Xiong, Jiwei Zhang, Yan Chen, Yi Zhang, Fan Yang · 2022 · EBioMedicine
  76. TAp73 opposes tumor angiogenesis by promoting hypoxia-inducible factor 1α degradation
    Ivano Amelio, Satoshi Inoue, Elke Katrin Markert, Arnold J. Levine, Richard A. Knight, Tak W. Mak, Gerry Melino · 2014 · Proceedings of the National Academy of Sciences
  77. The Role of Hypoxia in Glioblastoma Radiotherapy Resistance
    Agathe L. Chédeville, Patrícia A. Madureira · 2021 · Cancers
  78. Mechanisms underlying the health benefits of intermittent hypoxia conditioning
    Johannes Burtscher, Tom Citherlet, Alba Camacho-Cardeñosa, Marta Camacho-Cardeñosa, Antoine Raberin, Bastien Krumm, Erich Hohenauer, Margit Egg, Mona Lichtblau, Julian Müller et al. · 2023 · The Journal of Physiology
  79. HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia
    Talía Velasco-Hernández, Axel Hyrenius Wittsten, Matilda Rehn, David Bryder, Jörg Cammenga · 2014 · Blood
  80. Therapeutic m 6 A Eraser ALKBH5 mRNA-Loaded Exosome–Liposome Hybrid Nanoparticles Inhibit Progression of Colorectal Cancer in Preclinical Tumor Models
    Wu, Shenshen, Yun, Jun, Tang, Weiyan, Familiari, Giuseppe, Relucenti, Michela, Wu, Jiong, Li, Xiaobo, Chen, Hanqing, Chen, Rui · 2023 · ACS Nano
  81. Macrophage HIF-2α Ameliorates Adipose Tissue Inflammation and Insulin Resistance in Obesity
    Sung Sik Choe, Kyung Cheul Shin, Sojeong Ka, Yun Kyung Lee, Jang‐Soo Chun, Jae Bum Kim · 2014 · Diabetes
  82. Hypoxia in Breast Cancer—Scientific Translation to Therapeutic and Diagnostic Clinical Applications
    Ying Zhang, Hongyi Zhang, Minghong Wang, Thomas Schmid, Zhaochen Xin, Lora Kozhuharova, Wai-Kin Yu, Yu‐An Huang, Fengfeng Cai, Ewelina Maria Biskup · 2021 · Frontiers in Oncology
  83. TRAF6 Upregulates Expression of HIF-1α and Promotes Tumor Angiogenesis
    Heng Sun, Xuebing Li, Ya Jie Meng, Fan Li, Min Li, Jing Susan Fang · 2013 · Cancer Research
  84. Stress-induced cleavage of Myc promotes cancer cell survival
    Maralice Conacci‐Sorrell, Celine Ngouenet, Sarah Anderson, Thomas Brabletz, Robert N. Eisenman · 2014 · Genes & Development
  85. Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy
    Leila Haery, Ryan C. Thompson, Thomas D. Gilmore · 2015 · Genes & Cancer
  86. Mitochondria targeting by environmental stressors: Implications for redox cellular signaling
    Chuck C. Blajszczak, Marcelo Gialluisi Bonini · 2017 · Toxicology
  87. HIF 3α: the little we know
    Ravenna, Linda, Salvatori, Luisa, Russo, Matteo A. · 2016 · The FEBS Journal
  88. microRNA-138 plays a role in hypoxic pulmonary vascular remodelling by targeting Mst1
    Shanshan Li, Yajuan Ran, Dandan Zhang, Jianguo Chen, Shuzhen Li, Daling Zhu · 2013 · Biochemical Journal
  89. Inhibition of succinate dehydrogenase by the mitochondrial chaperone TRAP1 has anti-oxidant and anti-apoptotic effects on tumor cells
    Giulia Guzzo, Marco Sciacovelli, Paolo Bernardi, Andrea Rasola · 2014 · Oncotarget
  90. CDK8 Kinase Activity Promotes Glycolysis
    Matthew D. Galbraith, Zdeněk Andrysík, Ahwan Pandey, Maria Hoh, Elizabeth A. Bonner, Amanda A. Hill, Kelly D. Sullivan, Joaquin Maximiliano Espinosa · 2017 · Cell Reports
  91. The multifaceted von Hippel–Lindau tumour suppressor protein
    Claire M. Robinson, Michael Ohh · 2014 · FEBS Letters
  92. Metabolic Plasticity of Tumor Cell Mitochondria
    Giuseppe Cannino, Francesco Ciscato, Ionica Masgras, Carlos Sànchez‐Martìn, Andrea Rasola · 2018 · Frontiers in Oncology
  93. The Interplay Between Tumor Suppressor p53 and Hypoxia Signaling Pathways in Cancer
    Cen Zhang, Juan Liu, Jianming Wang, Tianliang Zhang, Dandan Xu, Wenwei Hu, Zhaohui Feng · 2021 · Frontiers in Cell and Developmental Biology
  94. Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
    Toni K. Choueiri, David F. McDermott, Jaime Rafael Merchan, Todd Michael Bauer, Robert A. Figlin, Elisabeth I. Heath, Marc Dror Michaelson, Edward R. Arrowsmith, Anishka D'souza, Zhao Song et al. · 2023 · The Lancet Oncology
  95. The impact of hypoxia in pancreatic cancer invasion and metastasis
    Begoña Díaz, Angela Yuen · 2014 · Hypoxia
  96. Biology of advanced uveal melanoma and next steps for clinical therapeutics
    Jason J. Luke, Pierre L. Triozzi, Kyle Christopher McKenna, Erwin G. Van Meir, Jeffrey E. Gershenwald, Boris C. Bastian, Jorge Silvio Gutkind, Anne M. Bowcock, HOWARD Z. STREICHER, Poulam M. Patel et al. · 2014 · Pigment Cell & Melanoma Research
  97. The reciprocal function and regulation of tumor vessels and immune cells offers new therapeutic opportunities in cancer
    Rindert Missiaen, Massimiliano Mazzone, Gabriele Bergers · 2018 · Seminars in Cancer Biology
  98. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
    Xiaodong Hao, Yidan Ren, Maoxiao Feng, Qin Wang, Yunshan Wang · 2021 · Biomedicine & Pharmacotherapy
  99. Stearic acid induces proinflammatory cytokine production partly through activation of lactate-HIF1α pathway in chondrocytes
    Hongming Miao, Liang Chen, Lijun Hao, Xuan Zhang, Yujuan Chen, Zhihua Ruan, Houjie Liang · 2015 · Scientific Reports
  100. Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia
    Rodrigo Almeida Toledo, Camilo Jiménez, Gustavo Armaiz-Peña, Carlota Arenillas, Jaume Capdevila, Patricia L. M. Dahia · 2022 · Endocrine Reviews